Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF)
نویسندگان
چکیده
منابع مشابه
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
AIM Patients hospitalized for acute heart failure (AHF) differ with respect of many clinical characteristics which may influence their prognosis and response to treatment. We have assessed possible differences in the effects of serelaxin on dyspnoea relief, 60 Day outcomes and 180 Day mortality across patient subgroups in the RELAX-AHF trial. METHODS AND RESULTS Subgroups were based on pre-sp...
متن کاملDyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
AIMS Although dyspnoea is the most common cause of admission for acute heart failure (AHF), more needs to be known about its clinical course and prognostic significance. METHODS AND RESULTS The Pre-RELAX-AHF study randomized 232 subjects with AHF to placebo or four doses of relaxin and evaluated early (6-24 h Likert scale) and persistent [change in visual analogue scale area under the curve (...
متن کاملAcute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
BACKGROUND Omecamtiv mecarbil (OM) is a selective cardiac myosin activator that increases myocardial function in healthy volunteers and in patients with chronic heart failure. OBJECTIVES This study evaluated the pharmacokinetics, pharmacodynamics, tolerability, safety, and efficacy of OM in patients with acute heart failure (AHF). METHODS Patients admitted for AHF with left ventricular ejec...
متن کاملRationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
AIMS Although loop diuretics are the most commonly used drugs in acute heart failure (AHF) treatment, their short-term and long-term effects are relatively unknown. The significance of worsening renal function occurrence during intravenous treatment is not clear enough. This trial aims to clarify all these features and contemplate whether continuous infusion is better than an intermittent strat...
متن کاملSynthesis of AHF in
BLOOD, VOL. 23, No. 2 (FEBRUARY), 1964 By Jitssic & H. Li wis A HEMORRAGIC DISEASE, first described by von Willebrand in 1926’ in a large family living on the Aland Islands, has gone through a fascinating diagnostic metamorphosis. Initially it was thought to be due to a platelet abnormality,2’3 later to a vascular abnormality;4’5 more recently, to lack of a plasma factor( s ) .#{176} ‘ This cha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The American Journal of Cardiology
سال: 2017
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2017.03.031